embelin has been researched along with Cell Transformation, Neoplastic in 2 studies
embelin: from Embelia fruit (Myrsinaceae)
embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We previously reported that embelin suppresses colitis-associated tumorigenesis." | 7.83 | Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer. ( Dai, Y; Jiao, H; Qiao, L; Shuai, X; Teng, G; Wang, W; Wu, T; Zhang, R; Zhao, P, 2016) |
| "Embelin is a small molecule inhibitor of X-linked inhibitor of apoptosis protein (XIAP), with antioxidant, anti-inflammatory, and antitumor activities." | 5.40 | Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. ( Dai, Y; George, J; Hebbard, L; Jiao, H; Qiao, L; Teng, G; Wang, W; Wang, Y; Zhang, R, 2014) |
| " We previously reported that embelin suppresses colitis-associated tumorigenesis." | 3.83 | Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer. ( Dai, Y; Jiao, H; Qiao, L; Shuai, X; Teng, G; Wang, W; Wu, T; Zhang, R; Zhao, P, 2016) |
| "Embelin is a small molecule inhibitor of X-linked inhibitor of apoptosis protein (XIAP), with antioxidant, anti-inflammatory, and antitumor activities." | 1.40 | Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling. ( Dai, Y; George, J; Hebbard, L; Jiao, H; Qiao, L; Teng, G; Wang, W; Wang, Y; Zhang, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y | 2 |
| Jiao, H | 2 |
| Teng, G | 2 |
| Wang, W | 2 |
| Zhang, R | 2 |
| Wang, Y | 1 |
| Hebbard, L | 1 |
| George, J | 1 |
| Qiao, L | 2 |
| Wu, T | 1 |
| Shuai, X | 1 |
| Zhao, P | 1 |
2 other studies available for embelin and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
Topics: Animals; Benzoquinones; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Trans | 2014 |
Macrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer.
Topics: Animals; Benzoquinones; Cell Transformation, Neoplastic; Cells, Cultured; Colitis; Colon; Colonic Ne | 2016 |